BIGG

VA/DoD clinical practice guideline for the management of headache

U.S. Government. USA Department of Defense. USA Department of Veterans Affairs.

The VA and DoD Evidence-Based Practice Work Group (EBPWG) was established and first chartered in 2004, with a mission to advise the VA/DoD Health Executive Committee “on the use of clinical and epidemiological evidence to improve the health of the population . . .” across the Veterans Health Administ...

Céphalée/traitement médicamenteux, Céphalée/classification, Soins centrés sur le patient/normes, Neurostimulation électrique transcutanée, Antagonistes des récepteurs aux angiotensines/usage thérapeutique, Inhibiteurs de l'enzyme de conversion de l'angiotensine/usage thérapeutique, Antidépresseurs/usage thérapeutique, Anticonvulsivants/usage thérapeutique, Antagonistes bêta-adrénergiques/usage thérapeutique, Céphalée/thérapie

Texte intégral

Headaches in over 12s: diagnosis and management

England. National Institute for Health and Care Excellence.

This guideline covers advice on the diagnosis and management of tension-type headache, migraine (including migraine with aura and menstrual-related migraine), cluster headache and medication overuse headache in young people (aged 12 years and older) and adults. It aims to improve the recognition and mana...

Céphalée/diagnostic, Céphalée/thérapie, Céphalée/traitement médicamenteux, Topiramate/usage thérapeutique, Amitriptyline/usage thérapeutique, Pizotifène/usage thérapeutique

Texte intégral

European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention

Sacco, S; Bendtsen, L; Ashina, M; Reuter, U; Terwindt, G; Mitsikostas, DD; Martelletti, P.

J. Head. Pain; 20 (6), 2019

BACKGROUND AND AIM: Monoclonal antibodies acting on the calcitonin gene-related peptide or on its receptor are new drugs to prevent migraine. Four monoclonal antibodies have been developed: one targeting the calcitonin gene-related peptide receptor (erenumab) and three targeting the calcitonin gene-relat...

Migraines, Migraines/diagnostic, Migraines/traitement médicamenteux, Migraines/thérapie, Migraines/prévention et contrôle, Récepteurs du peptide relié au gène de la calcitonine/usage thérapeutique, Peptide relié au gène de la calcitonine/usage thérapeutique, Céphalée, Céphalée/traitement médicamenteux, Céphalée/diagnostic, Céphalée/thérapie, Céphalée/prévention et contrôle

Texte intégral (lien principal) Texte intégral (lien alternatif)